                                SEQUENCE LISTING

<110> Yarranton, Geoffrey T.
      KaloBios Pharmaceuticals, Inc.

<120> A Method of Treating a Staphylococcus Infection
  in a Patient Having a Low-Level Pathogenic
  Pseudomonas aeruginosa Infection
  

<130> 021167-003710PC

<140> WO PCT/US10/61636   
<141> 2010-12-21  

<150> US 61/288,977       
<151> 2009-12-22  

<160> 55

<170> FastSEQ for Windows Version 4.0

<210> 1
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH1 Vh region

<400> 1
Glu Ile Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15      
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Asp His
            20                  25                  30          
Ala Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45              
Gly Trp Ile Ser Pro Tyr Ser Gly Asn Pro Asn Tyr Ala Gln Ser Leu
    50                  55                  60                  
Gln Gly Arg Val Ser Leu Thr Thr Asp Arg Ser Thr Arg Thr Ala Tyr
65                  70                  75                  80  
Met Glu Leu Arg Ser Leu Lys Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Phe Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 2
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 2
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Val Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Ser Trp
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Gly Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 3
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 3
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Ala
            20                  25                  30          
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Trp Tyr Asn Gly Lys Glu Ile Ser Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Pro Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Ser Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 4
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 4
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Trp
            20                  25                  30          
Val Ala Trp Tyr Gln Gln Arg Pro Gly Lys Ala Pro Asn Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Ser Leu Lys Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 5
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 5
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Ser Phe Ser Ser Tyr
            20                  25                  30          
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Trp Tyr Asn Gly Lys Glu Ile Ser Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Pro Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Ser Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 6
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 6
Ala Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 7
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 7
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Val Gly Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Trp Tyr Asn Gly Lys Glu Ile Ser Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Leu Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Ser Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 8
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 8
Asp Ile Gln Met Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Arg Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Ser Ala Ala Ser Ser Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Val Ser Gly Thr Asp Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65                  70                  75                  80  
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 9
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 9
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Val Gly Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Trp Tyr Asn Gly Lys Glu Ile Ser Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Val Ser Arg Asp Asn Pro Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Ser Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 10
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 10
Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Ala Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 11
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 11
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Gly
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Thr Ala
            20                  25                  30          
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Trp Tyr Asn Gly Lys Glu Ile Ser Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Val Phe Arg Asp Asn Pro Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Ser Ser Leu Arg Thr Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 12
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 12
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Trp
            20                  25                  30          
Val Ala Trp Tyr Gln Gln Arg Pro Gly Lys Ala Pro Asn Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Ser Leu Lys Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 13
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 13
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Pro Leu His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ser Phe Ile Ser Tyr Asp Gly Ser Glu Lys Tyr Tyr Ala Ser Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 14
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 14
Asp Ile Gln Leu Thr Gln Ser Pro Ser Phe Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Gly Ile Ser Thr Tyr
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Ala Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Val Ala Thr Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 15
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 15
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Thr Ala Ser Gly Phe Ser Phe Ser Ser Tyr
            20                  25                  30          
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Trp Tyr Asp Gly Arg Asn Lys Tyr Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 16
<211> 108
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaIII subclass V-L region

<400> 16
Glu Ile Val Leu Thr Gln Phe Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15      
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Asn Val Gly Ser Ala
            20                  25                  30          
Tyr Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45              
Ile Tyr Gly Ala Ser Arg Arg Ala Pro Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60                  
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Arg Leu Glu
65                  70                  75                  80  
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro
                85                  90                  95      
Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105             


<210> 17
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 17
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Gly Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Trp Tyr Asp Gly Tyr Asn Lys Asp Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Ile Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 18
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaIII subclass V-L region

<400> 18
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
 1               5                  10                  15      
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
        35                  40                  45              
Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65                  70                  75                  80  
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 19
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 19
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Pro Leu His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ser Phe Ile Ser Tyr Asp Gly Ser Glu Lys Tyr Tyr Ala Ser Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 20
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaIII subclass V-L region

<400> 20
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
 1               5                  10                  15      
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Phe
        35                  40                  45              
Tyr Ala Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65                  70                  75                  80  
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 21
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 21
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Leu Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Val Gly Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Gly Ile His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Asn Ile Trp Tyr Asp Gly Ser Ser Glu Ser Tyr Ile Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Val Ser Arg Asp Asp Ser Arg Asn Thr Val Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 22
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaIII subclass V-L region

<400> 22
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
 1               5                  10                  15      
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
        35                  40                  45              
Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65                  70                  75                  80  
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 23
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 23
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr
            20                  25                  30          
Pro Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Ser Tyr Asp Gly Ser Glu Lys Trp Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Glu Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Gln Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 


<210> 24
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 24
Asp Ile Gln Leu Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Ser Val Thr Ile Thr Cys Arg Ala Ser Glu Gly Val Asp Arg Trp
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Asp Asp Val Ala Thr Tyr Tyr Cys Gln His Phe Trp Gly Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 25
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 25
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr
            20                  25                  30          
Pro Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Ser Tyr Asp Gly Ser Glu Lys Trp Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Glu Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ser Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 


<210> 26
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 26
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr
            20                  25                  30          
Pro Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Ser Tyr Asp Gly Ser Glu Lys Trp Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Glu Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 


<210> 27
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 27
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Pro Leu His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ser Phe Ile Ser Tyr Asp Gly Ser Glu Lys Tyr Tyr Ala Ser Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 28
<211> 104
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody Vlambda subclass V-L region

<400> 28
Gln Ser Ala Leu Thr Gln Pro Ala Ser Val Ser Gly Ser Pro Gly Gln
 1               5                  10                  15      
Ser Ile Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Tyr Val Ser Trp
            20                  25                  30          
Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu Ile Ile Tyr Asp Val
        35                  40                  45              
Thr Asn Arg Pro Ser Gly Val Pro Asp Arg Phe Ser Gly Ser Lys Ser
    50                  55                  60                  
Gly Asn Thr Ala Ser Leu Thr Ile Ser Gly Leu Gln Ala Glu Asp Glu
65                  70                  75                  80  
Ala Asp Tyr Tyr Cys Gln His Phe Trp Ser Thr Pro Tyr Thr Phe Gly
                85                  90                  95      
Gly Gly Thr Lys Leu Thr Val Leu
            100                 


<210> 29
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 29
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Pro Leu His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ser Phe Ile Ser Tyr Asp Gly Ser Glu Lys Tyr Tyr Ala Ser Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Glu Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser Ser
        115                 120                 


<210> 30
<211> 106
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody Vlambda subclass V-L region

<400> 30
Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln
 1               5                  10                  15      
Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala
            20                  25                  30          
Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr
        35                  40                  45              
Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser
    50                  55                  60                  
Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu
65                  70                  75                  80  
Asp Glu Ala Asp Tyr Tyr Cys Gln His Phe Trp Ser Thr Pro Tyr Thr
                85                  90                  95      
Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105     


<210> 31
<211> 113
<212> PRT
<213> Homo sapiens

<220> 
<223> human germ-line VH1-18 antibody Vh region

<400> 31
Gln Val Gln Leu Val Gln Ser Gly Ala Glu Val Lys Lys Pro Gly Ala
 1               5                  10                  15      
Ser Val Lys Val Ser Cys Lys Ala Ser Gly Tyr Thr Phe Thr Ser Tyr
            20                  25                  30          
Gly Ile Ser Trp Val Arg Gln Ala Pro Gly Gln Gly Leu Glu Trp Met
        35                  40                  45              
Gly Trp Ile Ser Ala Tyr Asn Gly Asn Thr Asn Tyr Ala Gln Lys Leu
    50                  55                  60                  
Gln Gly Arg Val Thr Met Thr Thr Asp Thr Ser Thr Ser Thr Ala Tyr
65                  70                  75                  80  
Met Glu Leu Arg Ser Leu Arg Ser Asp Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
            100                 105                 110         
Ser
    

<210> 32
<211> 106
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody Vlambda subclass V-L region

<400> 32
Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln
 1               5                  10                  15      
Thr Val Thr Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Leu Tyr Ala
            20                  25                  30          
Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Leu Tyr
        35                  40                  45              
Ser Lys Asn Ser Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser
    50                  55                  60                  
Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Arg Ala Glu
65                  70                  75                  80  
Asp Glu Ala Asp Tyr Tyr Cys Gln His Phe Trp Ser Thr Pro Tyr Thr
                85                  90                  95      
Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105     


<210> 33
<211> 113
<212> PRT
<213> Homo sapiens

<220> 
<223> human germ-line VH3-30.3 antibody Vh region

<400> 33
Gln Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Ser Tyr
            20                  25                  30          
Ala Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Ser Tyr Asp Gly Ser Asn Lys Tyr Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Gln Met Asn Ser Leu Arg Ala Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Ala Phe Asp Ile Trp Gly Gln Gly Thr Met Val Thr Val Ser
            100                 105                 110         
Ser
    

<210> 34
<211> 109
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody Vlambda subclass V-L region

<400> 34
Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln
 1               5                  10                  15      
Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ala Tyr
            20                  25                  30          
Asn Tyr Val Ser Trp Tyr Gln Gln Tyr Pro Gly Lys Val Pro Lys Leu
        35                  40                  45              
Ile Ile Tyr Glu Val Thr Lys Arg Pro Ser Gly Val Pro Asp Arg Phe
    50                  55                  60                  
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu
65                  70                  75                  80  
Arg Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln His Phe Trp Ser Thr
                85                  90                  95      
Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 


<210> 35
<211> 124
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VH3 Vh region

<400> 35
Glu Val Gln Leu Val Glu Ser Gly Gly Gly Val Val Gln Pro Gly Arg
 1               5                  10                  15      
Ser Leu Arg Leu Ser Cys Ala Ala Ser Gly Phe Thr Phe Ser Asn Tyr
            20                  25                  30          
Pro Met His Trp Val Arg Gln Ala Pro Gly Lys Gly Leu Glu Trp Val
        35                  40                  45              
Ala Val Ile Ser Tyr Asp Gly Ser Glu Lys Trp Tyr Ala Asp Ser Val
    50                  55                  60                  
Lys Gly Arg Phe Thr Ile Ser Arg Asp Asn Ser Lys Asn Thr Leu Tyr
65                  70                  75                  80  
Leu Glu Met Asn Ser Leu Arg Pro Glu Asp Thr Ala Val Tyr Tyr Cys
                85                  90                  95      
Ala Arg Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp
            100                 105                 110         
Tyr Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
        115                 120                 


<210> 36
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 36
Asp Ile Gln Leu Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Ser Val Thr Ile Thr Cys Arg Ala Ser Glu Gly Val Asp Arg Trp
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Arg Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Thr Leu Gln Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Ser Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Asp Asp Val Ala Thr Tyr Tyr Cys Gln His Phe Trp Ser Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 37
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaI subclass V-L region

<400> 37
Asp Ile Gln Met Thr Gln Ser Pro Ser Ser Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Arg Trp
            20                  25                  30          
Val Ala Trp Tyr Gln Gln Arg Pro Gly Lys Ala Pro Asn Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Ser Leu Lys Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Glu Asp Ile Ala Thr Tyr Tyr Cys Gln Gln Phe Trp Gly Thr Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 38
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> human germ-line JH6 antibody J-segment

<400> 38
Gly Met Asp Val Trp Gly Gln Gly Thr Thr Val Thr Val Ser Ser
 1               5                  10                  15  


<210> 39
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> human germ-line VkappaI L12 antibody V-L region

<400> 39
Asp Ile Gln Met Thr Gln Ser Pro Ser Thr Leu Ser Ala Ser Val Gly
 1               5                  10                  15      
Asp Arg Val Thr Ile Thr Cys Arg Ala Ser Gln Ser Ile Ser Ser Trp
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Lys Ala Pro Lys Leu Leu Ile
        35                  40                  45              
Tyr Asp Ala Ser Ser Leu Glu Ser Gly Val Pro Ser Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Pro
65                  70                  75                  80  
Asp Asp Phe Ala Thr Tyr Tyr Cys Gln Gln Tyr Asn Ser Tyr Ser Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 40
<211> 107
<212> PRT
<213> Homo sapiens

<220> 
<223> human germ-line VkappaIII antibody V-L region

<400> 40
Glu Ile Val Met Thr Gln Ser Pro Ala Thr Leu Ser Val Ser Pro Gly
 1               5                  10                  15      
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Gln Ser Val Ser Ser Asn
            20                  25                  30          
Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu Ile
        35                  40                  45              
Tyr Gly Ala Ser Thr Arg Ala Thr Gly Ile Pro Ala Arg Phe Ser Gly
    50                  55                  60                  
Ser Gly Ser Gly Thr Glu Phe Thr Leu Thr Ile Ser Ser Leu Gln Ser
65                  70                  75                  80  
Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Tyr Asn Asn Trp Pro Tyr
                85                  90                  95      
Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105         


<210> 41
<211> 108
<212> PRT
<213> Homo sapiens

<220> 
<223> human germ-line Vlambda3 3l antibody V-L region

<400> 41
Ser Ser Glu Leu Thr Gln Asp Pro Ala Val Ser Val Ala Leu Gly Gln
 1               5                  10                  15      
Thr Val Arg Ile Thr Cys Gln Gly Asp Ser Leu Arg Ser Tyr Tyr Ala
            20                  25                  30          
Ser Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Val Leu Val Ile Tyr
        35                  40                  45              
Gly Lys Asn Asn Arg Pro Ser Gly Ile Pro Asp Arg Phe Ser Gly Ser
    50                  55                  60                  
Ser Ser Gly Asn Thr Ala Ser Leu Thr Ile Thr Gly Ala Gln Ala Glu
65                  70                  75                  80  
Asp Glu Ala Asp Tyr Tyr Cys Asn Ser Arg Asp Ser Ser Gly Asn His
                85                  90                  95      
Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105             


<210> 42
<211> 111
<212> PRT
<213> Homo sapiens

<220> 
<223> human germ-line Vlambda2 2c antibody V-L region

<400> 42
Gln Ser Ala Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln
 1               5                  10                  15      
Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Gly Tyr
            20                  25                  30          
Asn Tyr Val Ser Trp Tyr Gln Gln His Pro Gly Lys Ala Pro Lys Leu
        35                  40                  45              
Met Ile Tyr Glu Val Ser Lys Arg Pro Ser Gly Val Pro Asp Arg Phe
    50                  55                  60                  
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Leu
65                  70                  75                  80  
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Ser Ser Tyr Ala Gly Ser
                85                  90                  95      
Asn Asn Phe Val Val Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 110     


<210> 43
<211> 108
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody VkappaIII subclass V-L region

<400> 43
Glu Ile Val Leu Thr Gln Phe Pro Gly Thr Leu Ser Leu Ser Pro Gly
 1               5                  10                  15      
Glu Arg Ala Thr Leu Ser Cys Arg Ala Ser Asn Ser Val Gly Ala Tyr
            20                  25                  30          
Asn Leu Ala Trp Tyr Gln Gln Lys Pro Gly Gln Ala Pro Arg Leu Leu
        35                  40                  45              
Ile Tyr Gly Ala Ser Arg Arg Ala Pro Gly Ile Pro Asp Arg Phe Ser
    50                  55                  60                  
Gly Ser Gly Ser Gly Thr Asp Phe Thr Leu Thr Ile Asn Arg Leu Glu
65                  70                  75                  80  
Pro Glu Asp Phe Ala Val Tyr Tyr Cys Gln Gln Phe Trp Ser Thr Pro
                85                  90                  95      
Tyr Thr Phe Gly Gln Gly Thr Lys Leu Glu Ile Lys
            100                 105             


<210> 44
<211> 109
<212> PRT
<213> Homo sapiens

<220> 
<223> anti-type III secretion system (TTSS) V antigen
      (anti-PcrV) antibody Vlambda2 subclass V-L region

<400> 44
Gln Ser Val Leu Thr Gln Pro Pro Ser Ala Ser Gly Ser Pro Gly Gln
 1               5                  10                  15      
Ser Val Thr Ile Ser Cys Thr Gly Thr Ser Ser Asp Val Gly Ala Tyr
            20                  25                  30          
Asn Tyr Val Ser Trp Tyr Gln Gln Tyr Pro Gly Lys Val Pro Lys Leu
        35                  40                  45              
Ile Ile Tyr Glu Val Thr Lys Arg Pro Ser Gly Val Pro Asp Arg Phe
    50                  55                  60                  
Ser Gly Ser Lys Ser Gly Asn Thr Ala Ser Leu Thr Val Ser Gly Arg
65                  70                  75                  80  
Gln Ala Glu Asp Glu Ala Asp Tyr Tyr Cys Gln His Phe Trp Ser Thr
                85                  90                  95      
Pro Tyr Thr Phe Gly Gly Gly Thr Lys Leu Thr Val Leu
            100                 105                 


<210> 45
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-H
      complementarity-determining region 3 (CDR3)

<220> 
<221> VARIANT        
<222> (15)...(15)
<223> Xaa = Ile, Gln, Tyr or Ser

<400> 45
Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp Xaa
 1               5                  10                  15  


<210> 46
<211> 5
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-L
      complementarity-determining region 3 (CDR3)

<220> 
<221> VARIANT        
<222> (3)...(3)
<223> Xaa = Ser or Gly

<400> 46
Phe Trp Xaa Thr Pro
 1               5  


<210> 47
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-L
      complementarity-determining region 3 (CDR3)

<400> 47
Gln Gln Phe Trp Ser Thr Pro Tyr Thr
 1               5                  


<210> 48
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-L
      complementarity-determining region 3 (CDR3)

<400> 48
Gln His Phe Trp Gly Thr Pro Tyr Thr
 1               5                  


<210> 49
<211> 9
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-L
      complementarity-determining region 3 (CDR3)

<400> 49
Gln His Phe Trp Ser Thr Pro Tyr Thr
 1               5                  


<210> 50
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-H
      complementarity-determining region 3 (CDR3)

<400> 50
Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp Ile
 1               5                  10                  15  


<210> 51
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-H
      complementarity-determining region 3 (CDR3)

<400> 51
Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp Gln
 1               5                  10                  15  


<210> 52
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-H
      complementarity-determining region 3 (CDR3)

<400> 52
Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp Tyr
 1               5                  10                  15  


<210> 53
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-H
      complementarity-determining region 3 (CDR3)

<400> 53
Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Met Asp Ser
 1               5                  10                  15  


<210> 54
<211> 11
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS) V
      antigen (anti-PcrV) antibody V-H
      complementarity-determining region 3 (CDR3)
      minimal essential binding specificity determinamt (BSD)

<400> 54
Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr
 1               5                  10      


<210> 55
<211> 15
<212> PRT
<213> Artificial Sequence

<220> 
<223> synthetic anti-type III secretion system (TTSS)
      V antigen (anti-PcrV) antibody V-H
      complementarity-determining region 3 (CDR3)

<220> 
<221> VARIANT        
<222> (13)...(13)
<223> Xaa = Met or Phe

<220> 
<221> VARIANT        
<222> (15)...(15)
<223> Xaa = Ile, Ser or Gln

<400> 55
Asn Arg Gly Asp Ile Tyr Tyr Asp Phe Thr Tyr Ala Xaa Asp Xaa
 1               5                  10                  15  

